UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 351

Sortiert nach

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial

Molecular cancer, 2022-03, Vol.21 (1), p.84-84, Article 84

2022

Volltextzugriff (PDF)

Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: A population pharmacokinetic approach

Basic & clinical pharmacology & toxicology, 2019-07, Vol.125 (1), p.34-43

2019

Volltextzugriff (PDF)

Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational study

British journal of clinical pharmacology, 2021-04, Vol.87 (4), p.1890-1902

2021

Volltextzugriff (PDF)

Sediment provenance variations in the southern Okhotsk Sea over the last 180 ka: Evidence from light and heavy minerals

Palaeogeography, palaeoclimatology, palaeoecology, 2017-08, Vol.479, p.61-70

2017

Volltextzugriff (PDF)

Rare earth elements in fine-grained sediments of major rivers from the high-standing island of Taiwan

Journal of Asian earth sciences, 2013-06, Vol.69, p.39-47

2013

Volltextzugriff (PDF)

Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes

Frontiers in pharmacology, 2020-12, Vol.11, p.593982

2020

Volltextzugriff (PDF)

Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage

BMC medicine, 2021-12, Vol.19 (1), p.322-11, Article 322

2021

Volltextzugriff (PDF)

Effect of antiplatelet pretreatment on platelet aggregation and clinical outcomes in acute ischemic stroke patients treated with recombinant tissue-type plasminogen activator

Pharmazie, 2020-01, Vol.75 (1), p.23-26

2020

Volltextzugriff (PDF)

Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitor

PloS one, 2014-01, Vol.9 (1), p.e84985

2014

Volltextzugriff (PDF)

ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patients

Pharmazie, 2015-02, Vol.70 (2), p.97-102

2015

Volltextzugriff (PDF)

Alkenone surface hydrographic changes of the subarctic Northwestern Pacific since the last glacial: proxy limitations and implications of non-thermal environmental influences

Progress in earth and planetary science, 2020-06, Vol.7 (1), p.1-13, Article 22

2020

Volltextzugriff (PDF)

The association of ABCC3 promoter methylation with clopidogrel response in Chinese ischemic stroke patients

Pharmazie, 2014-10, Vol.69 (10), p.764-768

2014

Volltextzugriff (PDF)

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Clinical cancer research, 2022-07, Vol.28 (13), p.2807-2817

2022

Volltextzugriff (PDF)

Efffect of the ABCC3 -211C/T polymorphism on clopidogrel responsiveness in patients with percutaneous coronary intervention

Clinical and experimental pharmacology & physiology, 2013-08, Vol.40 (8), p.504-509

2013

Volltextzugriff (PDF)

A simple and sensitive HPLC–ESI-MS/MS method for the determination of andrographolide in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-02, Vol.877 (5), p.502-506

2009

Volltextzugriff (PDF)

Association of the use of amlodipine with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention

Pharmazie, 2014-11, Vol.69 (11), p.814-817

2014

Volltextzugriff (PDF)

Effect of antiplatelet pretreatment on safety and efficacy outcomes in acute ischemic stroke patients after intravenous thrombolysis: a systematic review and meta-analysis

Expert review of neurotherapeutics, 2019-04, Vol.19 (4), p.349-358

2019

Volltextzugriff (PDF)

CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients

Pharmazie, 2013-03, Vol.68 (3), p.183-186

2013

Volltextzugriff (PDF)

Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients

Pharmazie, 2012-12, Vol.67 (12), p.1026-1029

2012

Volltextzugriff (PDF)

Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male Volunteers

Clinical therapeutics, 2021-09, Vol.43 (9), p.e264-e273

2021

Volltextzugriff (PDF)

Effects of CYP2C19 Genetic Polymorphisms on the Pharmacokinetic and Pharmacodynamic Properties of Clopidogrel and Its Active Metabolite in Healthy Chinese Subjects

Clinical therapeutics, 2018-07, Vol.40 (7), p.1170-1178

2018

Volltextzugriff (PDF)

CYP2C19 681G > A polymorphism and pharmacokinetics of clopidogrel in Chinese healthy volunteers

Pharmazie, 2012-09, Vol.67 (9), p.795-797

2012

Volltextzugriff (PDF)

Pharmacokinetics of clopidogrel in healthy Chinese volunteers

Pharmazie, 2012-09, Vol.67 (9), p.792-794

2012

Volltextzugriff (PDF)

Efficacy and safety of dual versus mono antiplatelet therapy in patients with stroke or transient ischemic attack: An updated meta-analysis of 18 randomized controlled trials

Pharmazie, 2020-10, Vol.75 (10), p.516-523

2020

Volltextzugriff (PDF)

Experimental Investigation on Starting Process of Supersonic Single-stage Air Ejector

Journal of thermal science, 2012-08, Vol.21 (4), p.348-353

2012

Volltextzugriff (PDF)

1 – 25 von 351

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(324)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial

Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: A population pharmacokinetic approach

Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational study

Sediment provenance variations in the southern Okhotsk Sea over the last 180 ka: Evidence from light and heavy minerals

Rare earth elements in fine-grained sediments of major rivers from the high-standing island of Taiwan

Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes

Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage

Effect of antiplatelet pretreatment on platelet aggregation and clinical outcomes in acute ischemic stroke patients treated with recombinant tissue-type plasminogen activator

Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitor

ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patients

Alkenone surface hydrographic changes of the subarctic Northwestern Pacific since the last glacial: proxy limitations and implications of non-thermal environmental influences

The association of ABCC3 promoter methylation with clopidogrel response in Chinese ischemic stroke patients

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Efffect of the ABCC3 -211C/T polymorphism on clopidogrel responsiveness in patients with percutaneous coronary intervention

A simple and sensitive HPLC–ESI-MS/MS method for the determination of andrographolide in human plasma

Association of the use of amlodipine with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention

Effect of antiplatelet pretreatment on safety and efficacy outcomes in acute ischemic stroke patients after intravenous thrombolysis: a systematic review and meta-analysis

CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients

Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients

Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male Volunteers

Effects of CYP2C19 Genetic Polymorphisms on the Pharmacokinetic and Pharmacodynamic Properties of Clopidogrel and Its Active Metabolite in Healthy Chinese Subjects

CYP2C19 681G > A polymorphism and pharmacokinetics of clopidogrel in Chinese healthy volunteers

Pharmacokinetics of clopidogrel in healthy Chinese volunteers

Efficacy and safety of dual versus mono antiplatelet therapy in patients with stroke or transient ischemic attack: An updated meta-analysis of 18 randomized controlled trials

Experimental Investigation on Starting Process of Supersonic Single-stage Air Ejector

Suchergebnisse filtern